LobbyingManax Rutson Clinical Development lobbying by quarter
Manax Rutson Clinical Development's latest lobbying report covers Q2 2026, at $30K. The four quarters Q3 2025–Q2 2026 total $120K. Its first report covers Q2 2025; the issues it reports most are Health Issues.
Manax Rutson Clinical Development
- Latest quarter
- $30K
- Q2 2026 · 1 reports
- Last 12 months
- $120K
- Last 4 quarters
- vs last quarter
- 0.0%
- Q2 2026 against the quarter before
- First report
- Q2 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2025 | $20K | 1 |
| Q3 2025 | $30K | 1 |
| Q4 2025 | $30K | 1 |
| Q1 2026 | $30K | 1 |
| Q2 2026 | $30K | 1 |
Policy issues the reports name
- Health issues5 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES1 reports
- SENATE1 reports
Firms it paid
| Firm | ||
|---|---|---|
| JTB Srategies | $140K | 5 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 08/05for Q2 | JTB Srategies | $30K |
| 04/15for Q1 | JTB Srategies | $30K |
| 02/05for Q4 2025 | JTB Srategies | $30K |
| 25/11/06for Q3 2025 | JTB Srategies | $30K |
| 25/07/16for Q2 2025 | JTB Srategies | Under $5,000 |
| 25/07/16for Q2 2025 | JTB Srategies | $20K |
| 25/03/17for Q2 2025 | JTB Srategies | Under $5,000 |